The Increment of Choroidal Thickness in Euthyroid Graves’ Ophthalmopathy: Is It an Early Sign of Venous Congestion?

The Increment of Choroidal Thickness in Euthyroid Graves’ Ophthalmopathy: Is It an Early Sign of Venous Congestion?

Objective. Clinical manifestations of Graves’ ophthalmopathy (GO) are caused by the overcompression of orbital tissues within the restricted orbital bone cavity. Impaired ocular blood flow may disrupt the retinal microstructure and functions. In this study, we aimed to investigate the macular and ch...

Full description

Bibliographic Details
Main Authors:	Eylem Cagiltay, Fahrettin Akay, Ozgur Demir, Erdinç Aydın, Berkay Akmaz, Baris Pamuk
Format:	Article
Language:	English
Published:	Hindawi Limited 2018-01-01
Series:	Journal of Ophthalmology
Online Access:	http://dx.doi.org/10.1155/2018/5891531

Similar Items

The Influence of Prior Hyperthyroidism on Euthyroid Graves’ Ophthalmopathy
by: Karolien Termote, et al.
Published: (2014-01-01)

Thyroid antibody-negative euthyroid Graves’ ophthalmopathy
by: Arshiya Tabasum, et al.
Published: (2016-06-01)

Evaluation of the Effect of Proptosis on Choroidal Thickness in Graves’ Ophthalmopathy
by: Gamze Yıldırım, et al.
Published: (2020-08-01)

A Case of Euthyroid Graves’ Ophthalmopathy in a Patient Sero-Negative for TSH Receptor Autoantibody
by: Asami Hotta, et al.
Published: (2018-01-01)

Clinical course of thyroid function and thyroid associated-ophthalmopathy in patients with euthyroid Graves’ disease
by: Suzuki N, et al.
Published: (2018-04-01)

Changes in choroidal perfusion after orbital decompression surgery for Graves′ ophthalmopathy
by: Narieman Nik, et al.
Published: (2017-01-01)

Treatment of Graves' ophthalmopathy
Published: (2010-09-01)

Analysis of different choroidal stratification thickness under macular fovea in patients with early graves ophthalmopathy
by: Dan Zhang, et al.
Published: (2019-12-01)

Analysis in Choroidal Thickness in Patients with Graves’ Ophthalmopathy Using Spectral-Domain Optical Coherence Tomography
by: Nan Yu, et al.
Published: (2018-01-01)

Clinical evaluation of Graves ophthalmopathy
by: Janićijević-Petrović Mirjana A., et al.
Published: (2012-01-01)

Immunological Aspects of Graves’ Ophthalmopathy
by: Dominika Łacheta, et al.
Published: (2019-01-01)

Graves' ophthalmopathy: interdisciplinary approach
Published: (2010-12-01)

The Influence of Juvenile Graves’ Ophthalmopathy on Graves’ Disease Course
by: Jurate Jankauskiene, et al.
Published: (2017-01-01)

Total Thyroidectomy for the Treatment of Recurrent Graves' Disease With Ophthalmopathy
by: Ahmet Nart, et al.
Published: (2008-07-01)

Treatment of ophthalmopathy in the course of Graves’ disease
by: Magdalena Woźniak, et al.
Published: (2019-09-01)

Practical Guidelines Management of Graves Ophthalmopathy
by: Imam Subekti, et al.
Published: (2019-10-01)

Graves’ ophthalmopathy – thyroid eye disease
by: Dagna Siedlecka, et al.
Published: (2019-08-01)

Age Influences the Severity of Graves' Ophthalmopathy
by: Muh-Chiou Lin, et al.
Published: (2008-06-01)

Update on pathogenesis and immunology of Graves’ ophthalmopathy
by: Larysa Krajewska-Węglewicz, et al.
Published: (2018-12-01)

Graves’ Ophthalmopathy Misdiagnosed as Relapsing Conjunctivitis
by: Irini P. Chatziralli, et al.
Published: (2010-09-01)

Ocular surface changes in Graves’ ophthalmopathy
by: Rou Sun, et al.
Published: (2021-04-01)

Interpretation of management guidelines for Graves Ophthalmopathy in 2019
by: Yi Shao, et al.
Published: (2021-08-01)

Comparative evaluation of oculometric variables in graves' ophthalmopathy
by: Hélio Amante Miot, et al.
Published: (2009-01-01)

The association of carotid cavernous fistula with Graves′ ophthalmopathy
by: Ozlem Celik, et al.
Published: (2013-01-01)

The Role of Oxidative Stress in the Pathogenesis of Graves' Ophthalmopathy
by: Chieh-Chih Tsai, et al.
Published: (2009)

Cytokines as Targets of Novel Therapies for Graves’ Ophthalmopathy
by: Poupak Fallahi, et al.
Published: (2021-04-01)

Predictive Factors of Development of Graves’ Ophthalmopathy for Patients with Juvenile Graves’ Disease
by: Dalia Jarusaitiene, et al.
Published: (2016-01-01)

Evaluation of changes in choroidal thickness after implantable collamer lens surgery in high myopia patients with graves’ Ophthalmopathy (inactive phase)
by: Fanglin He, et al.
Published: (2020-08-01)

Comparison of intravitreal anti-vascular endothelial growth factor agents and treatment results in Irvine-Gass syndrome
by: Fahrettin Akay, et al.
Published: (2020-10-01)

Corticosteroid Pulse Therapy for Graves' Ophthalmopathy Reduces the Relapse Rate of Graves' Hyperthyroidism
by: Rosario Le Moli, et al.
Published: (2020-06-01)

Assessing quality of life in Taiwanese patients with Graves' ophthalmopathy
by: I-Chan Lin, et al.
Published: (2015-11-01)

Evaluation of the patients with Grave’s ophthalmopathy after the corticosteroids treatment
by: Janićijević-Petrović Mirjana, et al.
Published: (2012-01-01)

Maukirana grahonmada – Psychiatric manifestations of Graves' hyperthyroidism and ophthalmopathy?
by: Prasad Mamidi, et al.
Published: (2018-01-01)

Postural variation of exophthalmometry in Graves′ ophthalmopathy
by: Asad Rajvardhan, et al.
Published: (1990-01-01)

Update on the medical treatment of Graves&rsquo; ophthalmopathy
by: Gregory J Griepentrog, et al.
Published: (2009-12-01)

Graves′ ophthalmopathy-role of radiation therapy
by: Datta N, et al.
Published: (1987-01-01)

Clinical efficacy of orbital decompression in patients with Graves ophthalmopathy
by: Shao-Zhu Hu, et al.
Published: (2017-10-01)

Corticosteroids for Graves’ Ophthalmopathy: Systematic Review and Meta-Analysis
by: Xiaofang Tu, et al.
Published: (2018-01-01)

The Evolving Role of Selenium in the Treatment of Graves' Disease and Ophthalmopathy
by: Leonidas H. Duntas
Published: (2012-01-01)

Pathogenesis of orbital adipose tissue hypertrophy in Graves’ ophthalmopathy
by: Mei-Hsiu Chen, et al.
Published: (2008)